Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2015 12:40 ET | Source: Esperite N.V.

Esperite N.V. convenes EGM to approve new share option scheme

Esperite N.V. (Euronext: ESP, 'Esperite') announces it is convening an extraordinary general meeting of Shareholders ("EGM") to be held on Wednesday 23 December 2015 to approve its new share option...
November 11, 2015 12:40 ET | Source: Esperite N.V.

Esperite N.V. convenes EGM to approve new share option scheme

Esperite N.V. (Euronext: ESP, 'Esperite') announces it is convening an extraordinary general meeting of Shareholders ("EGM") to be held on Wednesday 23 December 2015 to approve its new share...
November 03, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE N.V. Trading Update. CryoSave stable, Genoma 45% growth

Zutphen, The Netherlands - 3 November 2015 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces its trading update for the quarter ended 30 September 2015. ESPERITE keeps growing...
November 03, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE N.V. Trading Update. CryoSave stable, Genoma 45% growth

Zutphen, The Netherlands - 3 November 2015 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces its trading update for the quarter ended 30 September 2015. ESPERITE keeps...
August 25, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE N.V. (ESP) publishes 2015 half-year results, total revenue increases over same period last year

CryoSave maintains new client intake but revenues are under pressure Genoma reports strong intake of sales and confirms global plan will be met despite of a 2 to 3 month delay compared to the...
August 25, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE N.V. (ESP) publishes 2015 half-year results, total revenue increases over same period last year

CryoSave maintains new client intake but revenues are under pressure Genoma reports strong intake of sales and confirms global plan will be met despite of a 2 to 3 month delay compared to the...
August 20, 2015 01:17 ET | Source: Esperite N.V.

Η ESPERITE (ESP) στο Βατικανό μαζί με το Κοινωφελές Ίδρυμα Ιωάννη Παύλου Β' για την Έρευνα και την Molipharma, τις δύο θυγατρικές του Καθολικού Πανεπιστημίου της Ιερής Καρδιάς

H GENOMA, εταιρεία του Ομίλου Esperite, από κοινού με το Καθολικό Πανεπιστήμιο της Ιερής Καρδιάς, FONDAZIONE GIOVANNI PAOLO II και την MOLIPHARMA, θα αναπτύξει στην Ιταλία τεστ με βάση την...
August 20, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (ESP) in Vaticano con la Fondazione di Ricerca a Cura Giovanni Paolo II e Molipharama, parte dell'UNIVERISITA' CATTOLICA DEL SACRO CUORE

GENOMA (società del Gruppo Esperite, leader europeo nell'ambito della genomica e proteomica), FONDAZIONE GIOVANNI PAOLO II e MOLIPHARMA (entrambi parte dell'Università Cattolica del Sacro Cuore),...
August 20, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (ESP) en el Vaticano con la Fundación Juan Pablo II para la Investigación y Molipharma, filiales de la UNIVERSIDAD CATOLICA DEL SAGRADO CORAZÓN

GENOMA, la división genética de Esperite, junto con la FUNDACION JUAN PABLO II PARA LA INVESTIGACION y MOLIPHARMA ambas parte de la Universidad Católica del Sagrado Corazón, desarrollarán en Italia...
August 20, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (ESP) in Vatican with John Paul II Foundation for Research and Molipharma, subsidiaries of CATHOLIC UNIVERSITY OF THE SACRED HEART

Esperite's GENOMA jointly with Catholic University of the Sacred Heart's FONDAZIONE GIOVANNI PAOLO II and MOLIPHARMA will develop NGS-based tests in Italy and project new diagnotics Genoma...